Туркменистан пополнил список из более чем 10-ти государств, одобривших российскую разработку против COVID-19 – «Спутник V». 18 января она была зарегистрирована и успешно прошла сертификацию в туркменском Минздраве.
As informed the general director of the Rosfond of direct investments K. Dmitriev, Turkmenistan became the first country in the Central Asian region to officially approve the use of the Sputnik V vaccine. Efficiency and safety of the drug as one of the advanced ways to counteract COVID-19 is recognized by the partners of the Foundation. According to K. Dmitriev, the vaccine was developed on the basis of a proven platform of human adenovirus vectors, which makes it possible to use it as a preventive agent against the spread of the virus.
Source: mfa.gov.tm
Add a comment.